TG Therapeutics | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 38.75B 4.31B 2024-12
Alaunos Therapeutics USD 4K 822K 2024-10
Amgen USD 23.01B 91M 2025-03
Ardelyx USD 77.83M 7.33M 2024-12
Arrowhead Research USD 220.54M 126.78M 2025-03
Bayer EUR 27.96B 993M 2025-03
Biogen USD 5.3B 231.4M 2025-03
Corcept Therapeutics USD 143.07M 2.29M 2025-03
Dynavax Technologies USD 68.38M 10.26M 2025-03
Gilead Sciences USD 12B 279M 2024-12
J&J USD 56.9B 6.58B 2025-03
Novartis USD 28.69B 560M 2024-12
PTC Therapeutics USD 595.39M 14.41M 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
TG Therapeutics USD 90.68M 34.43M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



TG Therapeutics Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.